Fmr LLC Immunome Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Immunome Inc. stock. As of the latest transaction made, Fmr LLC holds 4,210,943 shares of IMNM stock, worth $66.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,210,943

Previous 4,534,643 7.14%

Holding current value

$66.2 Million

Previous $112 Million 54.47%

% of portfolio

0.0%

Previous 0.01%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$11.54 - $22.11 $3.74 Million - $7.16 Million	-323,700 Reduced 7.14%	4,210,943 $51 Million
Q1 2024 May 13, 2024	BUY	$11.01 - $27.34 $6.92 Million - $17.2 Million	628,500 Added 16.09%	4,534,643 $112 Million
Q4 2023 Feb 13, 2024	BUY	$7.3 - $10.73 $28.5 Million - $41.9 Million	3,906,143 New	3,906,143 $41.8 Million
Q4 2021 Feb 14, 2022	SELL	$12.96 - $23.44 $414 - $750	-32 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$12.5 - $27.76 $2.83 Million - $6.29 Million	-226,424 Reduced 99.99%	32 $0
Q2 2021 Aug 13, 2021	BUY	$16.33 - $32.33 $3.7 Million - $7.32 Million	226,456 New	226,456 $3.92 Million

Others Institutions Holding IMNM

# of Institutions

115

Shares Held

43.4M

Call Options Held

67.2K

Put Options Held

65.9K

View Full List

About Immunome Inc.

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $191M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

More about IMNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account